Physician profile
Jonathan Paul Degner
NPI 1154604452
$2,042.59
in general payments reported to CMS, 2019-2025
11 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $260 · 2023: $1,172 · 2024: $149 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Travel and Lodging: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.61 |
| Travel and Lodging | $731.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $870.34 | 2023 | Vasoview Hemopro 2 |
| Baxter Healthcare | $546.35 | 2021-2025 | Floseal, Preveleak |
| Bolton Medical INC | $130.94 | 2022-2023 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $126.79 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Abbott Laboratories | $107.63 | 2022-2025 | Navitor, Epic |
| Atricure, INC. | $76.61 | 2022-2024 | |
| Depuy Synthes Sales INC. | $71.19 | 2024 | Matrixrib |
| Medtronic, INC. | $39.67 | 2025 | Aquamantys(Tm), Sonicision |
| Abiomed | $38.87 | 2025 | |
| Kls-Martin L.P. | $17.46 | 2022 | |
| Lemaitre Vascular, INC. | $16.74 | 2023 | Cardiocel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Degner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.